Compare the cost of using Mitra® Volumetric Absorptive Microsampling Technology (VAMS™) with that of conventional wet blood or plasma for the collection of samples for the determination of circulating concentrations of pharmaceuticals and biomarkers in drug development clinical trials.
For single site first administration to human studies (Phase I), blood and plasma samples are normally sent directly to the bioanalytical laboratory on a regular basis. However, for most multi-site studies (Phase II and III) samples are routinely sent from the various sites to a central laboratory where they are stored until the bioanalytical laboratory requires them for analysis. If your Phase I study has more than one study centre, or uses a central laboratory for the accumulation of samples prior to shipping to the bioanalytical laboratory, you may instead want to use the Phase II or Phase III models.
Select a phase to begin calculating. Note that you can use the calculators multiple times to model several study designs in different phases.